Drug used to treat HIV linked to lower bone mass in newborns

NIH study finds mothers’ use of tenofovir tied to lower bone mineral content in babies

Infants exposed in the womb to a drug used to treat HIV and reduce the transmission of HIV from mother to child, may have lower bone mineral content than those exposed to other anti-HIV drugs, according to a National Institutes of Health study.

Read more View All News

This page was last updated on Friday, January 21, 2022